Research Article

Prognostic Factors for Overall Survival of Patients with Prostate Cancer in Kyadondo County, Uganda

Table 3

Univariate and multivariate cox regression analysis for 3-year overall survival rate.

VariableUnivariate analysisMultivariate analysis
HR(95% CI)HR(95% CI)

Age (years)≤6010.21610.581
>600.69 (0.39–1.24)0.83 (0.43–1.60)
Pre-treatment PSA (ng/mL)≤2010.00710.346
>202.96 (1.34–6.57)1.05 (0.54–5.66)
Clinical stageI and II10.00610.039
III and IV3.34 (1.42–7.84)2.65 (1.78–4.19)
GS<810.00310.008
≥82.54 (1.37–4.70)1.88 (3–7.11)
TE≤50%10.10310.801
>50%1.67 (0.90–3.08)0.92 (0.49–1.71)
PNINo10.00110.176
Yes0.37 (0.21–0.67)0.63 (0.32–1.23)
LVINo10.000510.002
Yes0.25 (0.14–0.45)0.37 (0.18–0.69)

GS: Gleason score, PSA: prostatic specific antigen, TE: tumour extent, PNI: perineural invasion, LVI: lymphovascular invasion, CI: confidence interval, HR: hazard ratio. Reference HR = 1.